Escherichia coli vaccine - Emergent BioSolutions

Drug Profile

Escherichia coli vaccine - Emergent BioSolutions

Alternative Names: ETEC vaccine - Emergent BioSolutions; Traveller's diarrhoea vaccine - Emergent BioSolutions

Latest Information Update: 10 Nov 2010

Price : $50

At a glance

  • Originator Emergent BioSolutions
  • Class Escherichia coli vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Escherichia coli infections

Most Recent Events

  • 10 Nov 2010 Discontinued - Phase-I for Escherichia coli infections in United Kingdom (PO)
  • 07 Mar 2006 This vaccine is available for licensing (
  • 27 Jun 2005 Microscience has been acquired by Emergent BioSolutions
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top